TREATMENT OF PYELONEPHRITIS: BACTERIAL, DRUG AND HOST FACTORS IN SUCCESS OR FAILURE AMONG 252 PATIENTS.
D000900:Anti-Bacterial Agents; D002701:Chloramphenicol; D003091:Colistin; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D004358:Drug Therapy; D004754:Enterobacter; D004927:Escherichia coli Infections; D006801:Humans; D007709:Klebsiella; D009268:Nalidixic Acid; D009582:Nitrofurantoin; D011512:Proteus Infections; D011552:Pseudomonas Infections; D011704:Pyelonephritis; D013223:Statistics as Topic; D013449:Sulfonamides; D013752:Tetracycline
D000900:Anti-Bacterial Agents; D013449:Sulfonamides; D009268:Nalidixic Acid; D002701:Chloramphenicol; D009582:Nitrofurantoin; D013752:Tetracycline; D003091:Colistin
AEROBACTER; ANTIBIOTICS; CHLORAMPHENICOL; COLISTIN; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY; ESCHERICHIA COLI INFECTIONS; KLEBSIELLA; NALIDIXIC ACID; NITROFURANTOIN; PROTEUS INFECTIONS; PSEUDOMONAS INFECTIONS; PYELONEPHRITIS; STATISTICS; SULFONAMIDES; TETRACYCLINE